HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ichioka, N. Articles by Ikehara, S. Search for Related Content PubMed PubMed Citation Articles by Ichioka, N. Articles by Ikehara, S.

Prevention of Senile Osteoporosis in SAMP6 Mice by Intrabone Marrow Injection of Allogeneic Bone Marrow Cells

^a First Department of Pathology,
^b Department of Orthopedic Surgery,
^c Transplantation Center, and
^d Regeneration Research Center for Intractable Diseases, Kansai Medical University, Moriguchi City, Osaka, Japan;
^e Laboratory of Immunobiology, Department of Animal Development and Physiology, Division of Systemic Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Japan

Key Words. Bone marrow transplantation • Osteoporosis • SAMP6 mouse

Susumu Ikehara, M.D., Ph.D., First Department of Pathology, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8506, Japan. Telephone: 81-6-6993-9429; Fax: 81-6-6994-8283; e-mail: ikehara{at}takii.kmu.ac.jp

The SAMP6 mouse (a substrain of senescence-accelerated mice) spontaneously develops osteoporosis early in life and is, therefore, a useful model for examining the mechanisms underlying osteoporosis. We have recently established a new bone marrow transplantation (BMT) method: the bone marrow cells (BMCs) of normal allogeneic mice are directly injected into the bone marrow (BM) cavity of irradiated (5.5 Gy x 2) recipients (IBM-BMT). Using IBM-BMT, we attempted to prevent osteoporosis in SAMP6 mice. The hematolymphoid system was completely reconstituted with donor-type cells after IBM-BMT. Thus-treated SAMP6 mice showed marked increases in trabecular bones even at 12 months of age, and the bone mineral density remained similar to that of normal B6 mice. In concordance with these findings, urinary deoxypyridinoline also remained continuously low until 10 months of age, indicating that IBM-BMT was effective in the prevention of bone absorption.

In addition to the above, BM stromal cells in the treated SAMP6 mice were replaced with donor stromal cells, and the message level of interleukin-11 (IL-11), which is produced by the BM stromal cells and is known as an important factor in the regulation of bone remodeling, was restored to a level similar to that observed in normal B6 mice. Furthermore, the message level of IL-6, which is known to enhance osteoclastogenesis, was also restored to normal. These results indicate that the BM microenvironment was normalized after IBM-BMT and that the increased production of IL-11 and IL-6 ameliorated the imbalance between bone absorption and formation, resulting in the prevention of osteoporosis in SAMP6 mice.

This article has been cited by other articles:

				M. Dominici, R. Marino, V. Rasini, C. Spano, P. Paolucci, P. Conte, T. J. Hofmann, and E. M. Horwitz Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation Blood, April 15, 2008; 111(8): 4386 - 4391. [Abstract] [Full Text] [PDF]

				M. Inaba, Y. Adachi, H. Hisha, N. Hosaka, M. Maki, Y. Ueda, Y. Koike, T. Miyake, J. Fukui, Y. Cui, et al. Extensive Studies on Perfusion Method Plus Intra-Bone Marrow-Bone Marrow Transplantation Using Cynomolgus Monkeys Stem Cells, August 1, 2007; 25(8): 2098 - 2103. [Abstract] [Full Text] [PDF]

				Y. Ueda, M. Inaba, K. Takada, J. Fukui, Y. Sakaguchi, M. Tsuda, M. Omae, T. Kushida, H. Iida, and S. Ikehara Induction of Senile Osteoporosis in Normal Mice by Intra-Bone Marrow-Bone Marrow Transplantation from Osteoporosis-Prone Mice Stem Cells, June 1, 2007; 25(6): 1356 - 1363. [Abstract] [Full Text] [PDF]

				J. Fukui, M. Inaba, Y. Ueda, T. Miyake, N. Hosaka, A-H. Kwon, Y. Sakaguchi, M. Tsuda, M. Omae, Y. Kamiyama, et al. Prevention of Graft-Versus-Host Disease by Intra-Bone Marrow Injection of Donor T Cells Stem Cells, June 1, 2007; 25(6): 1595 - 1601. [Abstract] [Full Text] [PDF]

				Q. Li, H. Hisha, R. Yasumizu, T.-X. Fan, G.-X. Yang, Q. Li, Y.-Z. Cui, X.-L. Wang, C.-Y. Song, S. Okazaki, et al. Analyses of Very Early Hemopoietic Regeneration After Bone Marrow Transplantation: Comparison of Intravenous and Intrabone Marrow Routes Stem Cells, May 1, 2007; 25(5): 1186 - 1194. [Abstract] [Full Text] [PDF]

				Y. Koike, Y. Adachi, Y. Suzuki, M. Iwasaki, N. Koike-Kiriyama, K. Minamino, K. Nakano, H. Mukaide, A. Shigematsu, Y. Kiyozuka, et al. Allogeneic Intrabone Marrow-Bone Marrow Transplantation plus Donor Lymphocyte Infusion Suppresses Growth of Colon Cancer Cells Implanted in Skin and Liver of Rats Stem Cells, February 1, 2007; 25(2): 385 - 391. [Abstract] [Full Text] [PDF]

				K. Takada, M. Inaba, N. Ichioka, Y. Ueda, M. Taira, S. Baba, T. Mizokami, X. Wang, H. Hisha, H. Iida, et al. Treatment of Senile Osteoporosis in SAMP6 Mice by Intra-Bone Marrow Injection of Allogeneic Bone Marrow Cells Stem Cells, February 1, 2006; 24(2): 399 - 405. [Abstract] [Full Text] [PDF]